Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good storiesHow A Silly 11-Second Song About Dr Pepper Changed Her Life Overnight

feel good storiesSenior Cat Labeled 'Sad And Scared' Finds Forever Home

feel good storiesShe Could Have Kept Walking. Instead, She Stopped And Saved A Life

feel good storiesFamily On Walk Finds Kitten Covered In Ice, Stuck To Plastic She Was Hiding Under

feel good storiesNewborn Calf Barely Survives Freezing Cold, Then Finds Warmth With Kids

feel good video'You're a Unicorn': The Dementia Caregiver Who Just Stunned The American Idol Judges

feel good videoHis Kids Wanted To Help With His Videos, So He Let Them Narrate — It’s The Cutest Thing

feel good videoMeet Ella: She's 104, A WWII Veteran, And Swears By Peanut Butter

feel good videoNew Jersey Man Lets Robot Handle Snowstorm — Wakes Up To A Clear Driveway

feel good videoKid Knocks On Door To Ask If Their DOG Can Come Outside And Play